Methotrexate Attenuates Vascular Inflammation Through an Adenosine-microRNA-dependent Pathway

Overview

Journal Elife

Specialty Biology

Date 2021 Jan 8

PMID 33416495

Citations 12

Authors

Dafeng Yang

Stefan Haemmig

Haoyang Zhou

Daniel Perez-Cremades

Xinghui Sun

Lei Chen

Jie Li

Jorge Haneo-Mejia

Tianlun Yang

Ivana Hollan

Mark W Feinberg

Affiliations

Soon will be listed here.

Abstract

Endothelial cell (EC) activation is an early hallmark in the pathogenesis of chronic vascular diseases. MicroRNA-181b () is an important anti-inflammatory mediator in the vascular endothelium affecting endotoxemia, atherosclerosis, and insulin resistance. Herein, we identify that the drug methotrexate (MTX) and its downstream metabolite adenosine exert anti-inflammatory effects in the vascular endothelium by targeting and activating expression. Both systemic and endothelial-specific -deficient mice develop vascular inflammation, white adipose tissue (WAT) inflammation, and insulin resistance in a diet-induced obesity model. Moreover, MTX attenuated diet-induced WAT inflammation, insulin resistance, and EC activation in a -dependent manner. Mechanistically, MTX attenuated cytokine-induced EC activation through a unique adenosine-adenosine receptor A3-SMAD3/4- signaling cascade. These findings establish an essential role of endothelial in controlling vascular inflammation and that restoring in ECs by high-dose MTX or adenosine signaling may provide a potential therapeutic opportunity for anti-inflammatory therapy.

Citing Articles

Navigating Q fever: Current perspectives and challenges in outbreak preparedness.

Meles D, Khairullah A, Mustofa I, Wurlina W, Akintunde A, Suwasanti N Open Vet J. 2024; 14(10):2509-2524.

PMID: 39545195 PMC: 11560256. DOI: 10.5455/OVJ.2024.v14.i10.2.

Treating Cardiovascular Disease in the Inflammatory Setting of Rheumatoid Arthritis: An Ongoing Challenge.

Godbole S, Solomon J, Johnson M, Srivastava A, Carsons S, Belilos E Biomedicines. 2024; 12(7).

PMID: 39062180 PMC: 11275112. DOI: 10.3390/biomedicines12071608.

MicroRNA-181 in cardiovascular disease: Emerging biomarkers and therapeutic targets.

Lv B, He S, Li P, Jiang S, Li D, Lin J FASEB J. 2024; 38(9):e23635.

PMID: 38690685 PMC: 11068116. DOI: 10.1096/fj.202400306R.

Colchicine Blocks Abdominal Aortic Aneurysm Development by Maintaining Vascular Smooth Muscle Cell Homeostasis.

Chen M, Yang D, Zhou Y, Yang C, Lin W, Liu J Int J Biol Sci. 2024; 20(6):2092-2110.

PMID: 38617538 PMC: 11008260. DOI: 10.7150/ijbs.93544.

The Clinical Significance of Salusins in Systemic Sclerosis-A Cross-Sectional Study.

Nowaczyk J, Blicharz L, Zawistowski M, Sikora M, Zaremba M, Czuwara J Diagnostics (Basel). 2023; 13(5).

PMID: 36899991 PMC: 10001236. DOI: 10.3390/diagnostics13050848.

References

Sun X, Belkin N, Feinberg M . Endothelial microRNAs and atherosclerosis. Curr Atheroscler Rep. 2013; 15(12):372. PMC: 3859467. DOI: 10.1007/s11883-013-0372-2. View

Deyab G, Hokstad I, Whist J, Smastuen M, Agewall S, Lyberg T . Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis. Arthritis Res Ther. 2017; 19(1):232. PMC: 5646156. DOI: 10.1186/s13075-017-1439-1. View

Hasko G, Cronstein B . Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 2003; 25(1):33-9. DOI: 10.1016/j.it.2003.11.003. View

Yamasaki E, Soma Y, Kawa Y, Mizoguchi M . Methotrexate inhibits proliferation and regulation of the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by cultured human umbilical vein endothelial cells. Br J Dermatol. 2003; 149(1):30-8. DOI: 10.1046/j.1365-2133.2003.05407.x. View

Ridker P, Everett B, Thuren T, MacFadyen J, Chang W, Ballantyne C . Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 2017; 377(12):1119-1131. DOI: 10.1056/NEJMoa1707914. View

Sun X, He S, Wara A, Icli B, Shvartz E, Tesmenitsky Y . Systemic delivery of microRNA-181b inhibits nuclear factor-κB activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice. Circ Res. 2013; 114(1):32-40. PMC: 4051320. DOI: 10.1161/CIRCRESAHA.113.302089. View

Charles-Schoeman C, Lee Y, Shahbazian A, Wang X, Elashoff D, Curtis J . Improvement of High-Density Lipoprotein Function in Patients With Early Rheumatoid Arthritis Treated With Methotrexate Monotherapy or Combination Therapies in a Randomized Controlled Trial. Arthritis Rheumatol. 2016; 69(1):46-57. PMC: 5195879. DOI: 10.1002/art.39833. View

Thomou T, Mori M, Dreyfuss J, Konishi M, Sakaguchi M, Wolfrum C . Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature. 2017; 542(7642):450-455. PMC: 5330251. DOI: 10.1038/nature21365. View

Liao Y, Smyth G, Shi W . featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2013; 30(7):923-30. DOI: 10.1093/bioinformatics/btt656. View

10.

McNelis J, Olefsky J . Macrophages, immunity, and metabolic disease. Immunity. 2014; 41(1):36-48. DOI: 10.1016/j.immuni.2014.05.010. View

11.

Kisiel B, Kruszewski R, Juszkiewicz A, Raczkiewicz A, Bachta A, Tlustochowicz M . Methotrexate, Cyclosporine A, and Biologics Protect against Atherosclerosis in Rheumatoid Arthritis. J Immunol Res. 2015; 2015:759610. PMC: 4452098. DOI: 10.1155/2015/759610. View

12.

Kaeley G, MacCarter D, Pangan A, Wang X, Kalabic J, Ranganath V . Clinical Responses and Synovial Vascularity in Obese Rheumatoid Arthritis Patients Treated with Adalimumab and Methotrexate. J Rheumatol. 2018; 45(12):1628-1635. DOI: 10.3899/jrheum.171232. View

13.

Hjeltnes G, Hollan I, Forre O, Wiik A, Lyberg T, Mikkelsen K . Serum levels of lipoprotein(a) and E-selectin are reduced in rheumatoid arthritis patients treated with methotrexate or methotrexate in combination with TNF-α-inhibitor. Clin Exp Rheumatol. 2013; 31(3):415-21. View

14.

Loyer X, Potteaux S, Vion A, Guerin C, Boulkroun S, Rautou P . Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice. Circ Res. 2013; 114(3):434-43. DOI: 10.1161/CIRCRESAHA.114.302213. View

15.

Payne S, De Val S, Neal A . Endothelial-Specific Cre Mouse Models. Arterioscler Thromb Vasc Biol. 2018; 38(11):2550-2561. PMC: 6218004. DOI: 10.1161/ATVBAHA.118.309669. View

16.

Chan E, Cronstein B . Mechanisms of action of methotrexate. Bull Hosp Jt Dis (2013). 2013; 71 Suppl 1:S5-8. View

17.

Henao-Mejia J, Williams A, Goff L, Staron M, Licona-Limon P, Kaech S . The microRNA miR-181 is a critical cellular metabolic rheostat essential for NKT cell ontogenesis and lymphocyte development and homeostasis. Immunity. 2013; 38(5):984-97. PMC: 3738211. DOI: 10.1016/j.immuni.2013.02.021. View

18.

Gareus R, Kotsaki E, Xanthoulea S, van der Made I, Gijbels M, Kardakaris R . Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis. Cell Metab. 2008; 8(5):372-83. DOI: 10.1016/j.cmet.2008.08.016. View

19.

Xu Y, Wang Y, Yan S, Yang Q, Zhou Y, Zeng X . Regulation of endothelial intracellular adenosine via adenosine kinase epigenetically modulates vascular inflammation. Nat Commun. 2017; 8(1):943. PMC: 5643397. DOI: 10.1038/s41467-017-00986-7. View

20.

Ma S, Tian X, Zhang Y, Mu C, Shen H, Bismuth J . E-selectin-targeting delivery of microRNAs by microparticles ameliorates endothelial inflammation and atherosclerosis. Sci Rep. 2016; 6:22910. PMC: 4783714. DOI: 10.1038/srep22910. View